Author: Andy Dargon - Page 2
CPAP and BiPAP both treat sleep apnea, but they work differently. CPAP is the first choice for most people. BiPAP is for those who need two pressure levels or have other breathing conditions. Learn when each one is right for you.
Learn how to prevent low blood sugar during workouts with diabetes. Discover safe exercise strategies, carb timing, insulin adjustments, and how strength training and tech like CGMs can help you stay active without fear of hypoglycemia.
The FDA's ANDA process lets generic drugs reach the market faster and cheaper by proving they work the same as brand-name drugs. Learn how it works, why it saves billions, and what it means for your prescriptions.
As people age, liver and kidney changes slow drug processing, increasing the risk of side effects and hospitalizations. Learn how these changes affect common medications and what you can do to stay safe.
Learn how antiemetics, antihistamines, and steroids prevent dangerous reactions during CT scans and chemotherapy. Discover who needs pre-medication, the best drug combinations, and how hospitals are reducing errors.
Psoriatic arthritis links skin and joint inflammation in autoimmune disease. Learn symptoms, diagnosis, treatments, and how to protect your heart and joints.
Pharmacokinetic studies are the primary method used to prove generic drugs are equivalent to brand-name versions, measuring how the body absorbs and processes the drug. But they're not foolproof-especially for complex or narrow therapeutic index drugs.
Discover where to find free or low-cost medications at community clinics if you're uninsured or underinsured. Learn eligibility rules, how to locate clinics, and what medications are available.
When no generic exists, brand-name drugs can cost tens of thousands a month. Patient assistance programs can cover the full cost-but only if you know how to apply and avoid hidden traps like accumulator adjustments. Learn how to get free or low-cost meds when there's no cheaper option.
St. John’s Wort can slash HIV protease inhibitor levels by up to 81%, leading to treatment failure and drug resistance. This interaction is well-documented, dangerous, and still happening-despite decades of warnings.